On the contrary, Van Sprundel et al. showed a significantly reduced risk for CBC after risk-reducing surgery (1.3% vs. 46.4%) and a 5-year OS of 94% vs. 77% for BRCA1/2 mutation carrier (van Sprundel et al. 2005). The gene discussed is BRCA1; the disease is complete blood cell count.